Memory Impairment and Neuronal Dysfunction Induced by β-Amyloid Protein in Rats

Toshitaka Nabeshima, Atsumi Nitta

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Nabeshima, T. and Nitta, A. Memory Impairment and Neuronal Dysfunction Induced by β-Amyloid Protein in Rats. Tohoku J. Exp. Med., 1994, 174 (3), 241-249 Alzheimer's disease (AD) is characterized by the presence of senile plaques. The core of the plaque consists of β-amyloid protein. In AD patients, learning and memory are impaired with a concomitant loss of the cholinergic marker enzyme, choline acetyltransferase (ChAT). However, direct evidence that βamyloid protein is related to the impairment of learning and memory has not been demonstrated. In this study, we investigated whether memory impairment and neuronal dysfunction were produced after 2 weeks continuous infusion of β-amyloid protein (3, 30 and 300 pmol/day) into the cerebral ventricles in adult rats. To investigate the ability of learning and memory in β-amyloid protein-treated rats, water maze and passive avoidance tasks were carried out. The performance of both tasks in β-amyloid protein-treated rats was impaired. ChAT activity in the frontal cortex (3 and 30 pmol/day) and hippocampus (300 pmol/day) significantly decreased. These results suggest that β-amyloid protein is related to the impairment of learning and memory, and neurodegeneration, and that β-amyloid protein-treated rats could be used as an animal model for AD. β-amyloid protein; Alzheimer's disease; memory; choline acetyltransferase; rats.

Original languageEnglish
Pages (from-to)241-249
Number of pages9
JournalTohoku Journal of Experimental Medicine
Volume174
Issue number3
DOIs
Publication statusPublished - 01-01-1994
Externally publishedYes

Fingerprint

Amyloidogenic Proteins
Rats
Data storage equipment
Choline O-Acetyltransferase
Alzheimer Disease
Learning
Cerebral Ventricles
Aptitude
Amyloid Plaques
Task Performance and Analysis
Frontal Lobe
Cholinergic Agents
Hippocampus
Animals
Animal Models

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

@article{bc56a862b61843dbbb83abdcc35c0192,
title = "Memory Impairment and Neuronal Dysfunction Induced by β-Amyloid Protein in Rats",
abstract = "Nabeshima, T. and Nitta, A. Memory Impairment and Neuronal Dysfunction Induced by β-Amyloid Protein in Rats. Tohoku J. Exp. Med., 1994, 174 (3), 241-249 Alzheimer's disease (AD) is characterized by the presence of senile plaques. The core of the plaque consists of β-amyloid protein. In AD patients, learning and memory are impaired with a concomitant loss of the cholinergic marker enzyme, choline acetyltransferase (ChAT). However, direct evidence that βamyloid protein is related to the impairment of learning and memory has not been demonstrated. In this study, we investigated whether memory impairment and neuronal dysfunction were produced after 2 weeks continuous infusion of β-amyloid protein (3, 30 and 300 pmol/day) into the cerebral ventricles in adult rats. To investigate the ability of learning and memory in β-amyloid protein-treated rats, water maze and passive avoidance tasks were carried out. The performance of both tasks in β-amyloid protein-treated rats was impaired. ChAT activity in the frontal cortex (3 and 30 pmol/day) and hippocampus (300 pmol/day) significantly decreased. These results suggest that β-amyloid protein is related to the impairment of learning and memory, and neurodegeneration, and that β-amyloid protein-treated rats could be used as an animal model for AD. β-amyloid protein; Alzheimer's disease; memory; choline acetyltransferase; rats.",
author = "Toshitaka Nabeshima and Atsumi Nitta",
year = "1994",
month = "1",
day = "1",
doi = "10.1620/tjem.174.241",
language = "English",
volume = "174",
pages = "241--249",
journal = "Tohoku Journal of Experimental Medicine",
issn = "0040-8727",
publisher = "Tohoku University Medical Press",
number = "3",

}

Memory Impairment and Neuronal Dysfunction Induced by β-Amyloid Protein in Rats. / Nabeshima, Toshitaka; Nitta, Atsumi.

In: Tohoku Journal of Experimental Medicine, Vol. 174, No. 3, 01.01.1994, p. 241-249.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Memory Impairment and Neuronal Dysfunction Induced by β-Amyloid Protein in Rats

AU - Nabeshima, Toshitaka

AU - Nitta, Atsumi

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Nabeshima, T. and Nitta, A. Memory Impairment and Neuronal Dysfunction Induced by β-Amyloid Protein in Rats. Tohoku J. Exp. Med., 1994, 174 (3), 241-249 Alzheimer's disease (AD) is characterized by the presence of senile plaques. The core of the plaque consists of β-amyloid protein. In AD patients, learning and memory are impaired with a concomitant loss of the cholinergic marker enzyme, choline acetyltransferase (ChAT). However, direct evidence that βamyloid protein is related to the impairment of learning and memory has not been demonstrated. In this study, we investigated whether memory impairment and neuronal dysfunction were produced after 2 weeks continuous infusion of β-amyloid protein (3, 30 and 300 pmol/day) into the cerebral ventricles in adult rats. To investigate the ability of learning and memory in β-amyloid protein-treated rats, water maze and passive avoidance tasks were carried out. The performance of both tasks in β-amyloid protein-treated rats was impaired. ChAT activity in the frontal cortex (3 and 30 pmol/day) and hippocampus (300 pmol/day) significantly decreased. These results suggest that β-amyloid protein is related to the impairment of learning and memory, and neurodegeneration, and that β-amyloid protein-treated rats could be used as an animal model for AD. β-amyloid protein; Alzheimer's disease; memory; choline acetyltransferase; rats.

AB - Nabeshima, T. and Nitta, A. Memory Impairment and Neuronal Dysfunction Induced by β-Amyloid Protein in Rats. Tohoku J. Exp. Med., 1994, 174 (3), 241-249 Alzheimer's disease (AD) is characterized by the presence of senile plaques. The core of the plaque consists of β-amyloid protein. In AD patients, learning and memory are impaired with a concomitant loss of the cholinergic marker enzyme, choline acetyltransferase (ChAT). However, direct evidence that βamyloid protein is related to the impairment of learning and memory has not been demonstrated. In this study, we investigated whether memory impairment and neuronal dysfunction were produced after 2 weeks continuous infusion of β-amyloid protein (3, 30 and 300 pmol/day) into the cerebral ventricles in adult rats. To investigate the ability of learning and memory in β-amyloid protein-treated rats, water maze and passive avoidance tasks were carried out. The performance of both tasks in β-amyloid protein-treated rats was impaired. ChAT activity in the frontal cortex (3 and 30 pmol/day) and hippocampus (300 pmol/day) significantly decreased. These results suggest that β-amyloid protein is related to the impairment of learning and memory, and neurodegeneration, and that β-amyloid protein-treated rats could be used as an animal model for AD. β-amyloid protein; Alzheimer's disease; memory; choline acetyltransferase; rats.

UR - http://www.scopus.com/inward/record.url?scp=0028544333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028544333&partnerID=8YFLogxK

U2 - 10.1620/tjem.174.241

DO - 10.1620/tjem.174.241

M3 - Article

C2 - 7761989

AN - SCOPUS:0028544333

VL - 174

SP - 241

EP - 249

JO - Tohoku Journal of Experimental Medicine

JF - Tohoku Journal of Experimental Medicine

SN - 0040-8727

IS - 3

ER -